This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gorjestani, S Articles by Abdou, N. Search for Related Content PubMed PubMed Citation Articles by Gorjestani, S Articles by Abdou, N. Social Bookmarking                         What's this?

Extracellular signal–regulated kinase 1/2 signalling in SLE T cells is influenced by oestrogen and disease activity

Department of Biology, Pittsburg State University, Pittsburg, Kansas, USA

V Rider

Department of Biology, Pittsburg State University, Pittsburg, Kansas, USA

BF Kimler

Department of Radiation Oncology, The University of Kansas Medical Center, Kansas City, Kansas, USA

C Greenwell

Center for Rheumatic Disease, Allergy-Immunology, Kansas City, Missouri, USA

NI Abdou

Center for Rheumatic Disease, Allergy-Immunology, Kansas City, Missouri, USA

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs primarily in women of reproductive age. The disease is characterized by exaggerated T-cell activity and abnormal T-cell signalling. The mitogen-activated protein kinase (MAPK) pathway is involved in the maintenance of T-cell tolerance that fails in patients with SLE. Oestrogen is a female sex hormone that binds to nuclear receptors and alters the rate of gene transcription. Oestrogen can also act through the plasma membrane and rapidly stimulate second messengers including calcium flux and kinase activation. In this study, we investigated whether oestrogen influences the activation of MAPK signalling through the phosphorylation of extracellular signal–regulated kinase 1/2 (ERK1/2) in activated SLE T cells. SLE and control T cells were cultured in serum-free medium without and with oestradiol (10^–7 M) for 18 h. The T cells were activated with phorbol 12 myristate 13-acetate and ionomycin for various time points (0–60 min), and the amount of phosphorylated ERK1/2 was measured by immunoblotting. There were no differences in ERK1/2 phosphorylation between SLE and control T cells at 5 and 15 min after the activation stimulus. However, comparison between the amount of phosphorylated ERK1/2 in SLE T cells from the same patients cultured without and with oestradiol showed a significant oestrogen-dependent suppression (P = 0.48) of ERK1/2 in patients with inactive/mild systemic lupus erythematosus disease activity index (SLEDAI) (0–2) compared with patients with moderate (4–6) or active (8–12) SLEDAI scores. These results suggest that the suppression of MAPK through ERK1/2 phosphorylation is sensitive to oestradiol in patients with inactive or mild disease, but the sensitivity is not maintained when disease activity increases. Furthermore, studies are now necessary to understand the mechanisms by which oestrogen influences MAPK activation in SLE T cells.

Key Words: ERK 1/2 activation • MAPK signalling • oestrogen • SLE • T cell

Lupus, Vol. 17, No. 6, 548-554 (2008)
DOI: 10.1177/0961203307087982


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?